Peak Pharmaceuticals, Inc. announced that it will receive $318,500 in funding on April 24, 2023. The company will issue common shares in the transaction. The company will issue securities pursuant to exemption provided under Regulation D.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
5.2 USD | +29.35% | -5.45% | +200.58% |
1st Jan change | Capi. | |
---|---|---|
+200.58% | 98.81M | |
+1.64% | 79.84B | |
+1.50% | 75.23B | |
-16.22% | 51.63B | |
+31.33% | 50.22B | |
-22.83% | 47.78B | |
+22.46% | 43.07B | |
+57.98% | 36.75B | |
-11.11% | 24.41B | |
-18.33% | 23.89B |
- Stock Market
- Equities
- RMHI Stock
- News Retrieve Medical Holdings Inc
- Peak Pharmaceuticals, Inc. announced that it expects to receive $0.3185 million in funding